Organisation mondiale de la santé (OMS) · Governing Bodies documents

Sixty-sixth Regional Committee for Europe: Copenhagen, 12–15 September 2016: provisional agenda (annotated)

Organisation mondiale de la santé
Voir le document original

Le texte intégral est hébergé par l’organisation qui le publie. lawenc.com indexe les métadonnées et renvoie vers la source officielle.

Texte intégral

W ORL D H E A LT H O RG A N I Z AT IO N R EG I ON A L O F F I C E FO R EU R O P E UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark Telephone: +45 45 33 70 00 Fax: +45 45 33 70 01 Email: eugovernance@who.int Web: http://www.euro.who.int/en/who-we-are/governance Regional Committee for Europe EUR/RC66/2 Rev.1 Add.1 66th session Copenhagen, Denmark, 12–15 September 2016 9 September 2016 160638 Provisional agenda item 1(b) ORIGINAL: ENGLISH Provisional agenda (annotated) 1. Opening of the session (a) Election of the President, the Executive President, the Deputy Executive President and the Rapporteur (b) Adoption of the provisional agenda and the provisional programme 2. Addresses (a) Address by the Regional Director and report on the work of the Regional Office since the 65th session of the Regional Committee for Europe The Regional Committee is invited to review the Regional Director’s report on the work of the Regional Office for Europe 2014–2015 (EUR/RC66/5, EUR/RC66/Inf.Doc./1). A general debate will follow the Regional Director’s address, delegations are invited to share their views on progress and challenges. The Regional Committee is invited to adopt draft resolution EUR/RC66/Conf.Doc./1. (b) Address by the Director-General The address by the Director-General will be followed by a debate by the Regional Committee on the issues raised by the Director-General. (c) Address by Her Royal Highness the Crown Princess of Denmark (d) Address by Mr Christian Friis Bach, Executive Secretary of the United Nations Economic Commission for Europe 3. Matters arising from resolutions and decisions of the World Health Assembly and the Executive Board Agenda item 3 on Matters arising will be taken up jointly with agenda item 5(l) on WHO reform and will be discussed on Monday afternoon and on Wednesday morning. On Monday afternoon, the Regional Committee is invited to review the technical resolutions and decisions of particular relevance to the European Region adopted by the Sixty-ninth World Health Assembly in May 2016 (EUR/RC66/6). The discussion will also include the development of a draft global action plan on EUR/RC66/2 Rev.1 Add.1 page 2 public health response to dementia (EUR/RC66/6 Add.1) and the role of the health sector in the Strategic Approach to International Chemicals Management (EUR/RC66/6 Add.2). On Wednesday morning, the draft global implementation plan for the recommendations of the Review Committee on the Role of the International Health Regulation (2005) in the Ebola Outbreak and Response (EUR/RC66/26) will be presented and discussed jointly with the Reform of WHO’s work in health emergency management (EUR/RC66/25). 4. Report of the Twenty-third Standing Committee of the Regional Committee for Europe The Regional Committee is invited to review the report of the Twenty-third Standing Committee of the Regional Committee for Europe (EUR/RC66/4, EUR/RC66/4 Add.1) and to adopt draft resolution EUR/RC66/Conf.Doc./2. 5. Policy and technical topics (a) Health in the 2030 Agenda for Sustainable Development and its relation to Health 2020 (b) Midterm progress report on Health 2020 implementation and the way forward Agenda items 5(a) and 5(b) will be discussed together in one session covering: – Midterm progress report on Health 2020 implementation (EUR/RC66/16) – Towards a roadmap to implement the 2030 Agenda for Sustainable Development in the WHO European Region (EUR/RC66/17) and its financial implications (EUR/RC66/17 Add.1) – Midterm progress report on implementation of the European Action Plan for Strengthening Public Health Capacities and Services (EUR/RC66/19, EUR/RC66/Inf.Doc./3, EUR/RC66/Inf.Doc./4). During the discussion, delegations are invited to share their views on the following questions. – What do you consider as the most important achievement in the implementation of Health 2020, in particular with regard to enabling functions used at the regional and/or national levels? Any examples? – What key steps in public health strengthening has your country taken towards achieving positive health and well-being outcomes for the population as a whole? – How will the health aspects of the 2030 Agenda for Sustainable Development be implemented at the national level in your country? What would you do differently based on your experience with implementing Health 2020? What could the Regional Office do to support the implementation process? EUR/RC66/2 Rev.1 Add.1 page 3 The Regional Committee is invited to adopt draft resolution EUR/RC66/Conf.Doc./13. (c) Action plan for the prevention and control of noncommunicable diseases in the WHO European Region The Regional Committee is invited to discuss the Action plan for the prevention and control of noncommunicable diseases in the WHO European Region (EUR/RC66/11, EUR/RC66/Inf.Doc./2) and its financial implications (EUR/RC66/11 Add.1), and to share their views on the way forward. The Regional Committee is invited to adopt draft resolution EUR/RC66/Conf.Doc./7. (d) Action plan for the health sector response to HIV in the WHO European Region The Regional Committee is invited to discuss the Action plan for the health sector response to HIV in the WHO European Region (EUR/RC66/9) and its financial implications (EUR/RC66/9 Add.1), and to adopt draft resolution EUR/RC66/Conf.Doc./5. (e) Action plan for the health sector response to viral hepatitis in the WHO European Region The Regional Committee is invited to discuss the Action plan for the health sector response to viral hepatitis in the WHO European Region (EUR/RC66/10) and its financial implications (EUR/RC66/10 Add.1), and to adopt draft resolution EUR/RC66/Conf.Doc./6. (f) Strategy and action plan for refugee and migrant health in the WHO European Region The Regional Committee is invited to discuss the Strategy and action plan for refugee and migrant health in the WHO European Region (EUR/RC66/8) and its financial implications (EUR/RC66/8 Add.1), and to adopt draft resolution EUR/RC66/Conf.Doc./4. (g) Strengthening people-centred health systems in the WHO European Region: framework for action on integrated health services delivery The Regional Committee is invited to discuss Strengthening people-centred health systems in the WHO European Region: framework for action on integrated health services delivery (EUR/RC66/15) and its financial implications (EUR/RC66/15 Add.1), and to adopt draft resolution EUR/RC66/Conf.Doc./11. (h) Strategy on women’s health and well-being in the WHO European Region The Regional Committee is invited to discuss the Strategy on women’s health and well-being in the WHO European Region (EUR/RC66/14) and its financial implications (EUR/RC66/14 Add.1), and to adopt draft resolution EUR/RC66/Conf.Doc./10. EUR/RC66/2 Rev.1 Add.1 page 4 (i) Action plan for sexual and reproductive health: towards achieving the 2030 Agenda for Sustainable Development in Europe – leaving no one behind The Regional Committee is invited to discuss the Action plan for sexual and reproductive health: towards achieving the 2030 Agenda for Sustainable Development in Europe – leaving no one behind (EUR/RC66/13) and its financial implications (EUR/RC66/13 Add.1), and to adopt draft resolution EUR/RC66/Conf.Doc./9. (j) Action plan to strengthen the use of evidence, information and research for policy-making in the WHO European Region The Regional Committee is invited to discuss the Action plan to strengthen the use of evidence, information and research for policy-making in the WHO European Region (EUR/RC66/12) and its financial implications (EUR/RC66/12 Add.1), and to adopt draft resolution EUR/RC66/Conf.Doc./8. (k) Proposed programme budget 2018–2019 The Regional Committee is invited to discuss documents EUR/RC66/20 and EUR/RC66/27. (l) WHO reform: progress and implications for the European Region Agenda item 5(l) will be taken jointly with item 3 on Matters arising from resolutions and decisions of the World Health Assembly and the Executive Board. On Monday afternoon, the Framework for Engagement with Non-State Actors (FENSA) and Governance reform issues resulting from the Open- ended Intergovernmental Meeting on Governance Reform and Managerial Reforms (EUR/RC66/21) will be introduced and discussed. On Wednesday morning, the Reform of WHO’s work in health emergency management (EUR/RC66/25) will be presented and discussed jointly with the draft global implementation plan for the recommendations of the Review Committee on the Role of the International Health Regulations (2005) in the Ebola Outbreak and Response (EUR/RC66/26). (m) Progress reports The report on progress in category 6 will be taken up under item 5(l) on WHO reform, and will include accountability (EUR/RC66/24). The report on progress in category 4 (EUR/RC66/19) will be taken up during the discussion of technical items 5(a) and 5(b). The remaining progress reports will be discussed, without introductory presentations, in three separate debates: the first debate will cover categories 1 and 5 (EUR/RC66/18), the second debate will cover category 2 (EUR/RC66/18) and the final debate will cover category 3 (EUR/RC66/18, (EUR/RC66/23)). EUR/RC66/2 Rev.1 Add.1 page 5 Category 1: Communicable diseases • Progress and final report on the European action plan for HIV/AIDS 2012–2015 (resolution EUR/RC61/R8) • Renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and sustained support for polio-free status in the WHO European Region (resolution EUR/RC60/R12) • Progress and final report on malaria elimination in the WHO European Region (resolution EUR/RC52/R10) Category 2: Noncommunicable diseases • Action Plan for implementation of the European Strategy for the Prevention and Control of Noncommunicable Diseases 2012–2016 (resolution EUR/RC61/R3) • WHO European Declaration and Action Plan on the Health of Children and Young People with Intellectual Disabilities and their Families (resolution EUR/RC61/R5) Category 3: Promoting health through the life-course • Strategy and action plan on healthy ageing in Europe, 2012–2020 (resolution EUR/RC62/R6) • The Millennium Development Goals in the WHO European Region: Health systems and health of mothers and children – lessons learned (resolution EUR/RC57/R2) • The future of the European environment and health process (resolution EUR/RC60/R7) Category 4: Health systems • European Action Plan for Strengthening Public Health Capacities and Services (resolution EUR/RC62/R5) Category 5: Preparedness, surveillance and response • European strategic action plan on antibiotic resistance (resolution EUR/RC61/R6) Category 6: Corporate and enabling functions • Implementation of programme budget 2014–2015 • Compliance and audit (n) The Minsk Declaration on the Life-course Approach in the Context of Health 2020 The Regional Committee is invited to consider the Minsk Declaration on the Life-course Approach in the Context of Health 2020 (EUR/RC66/22) and to adopt draft resolution EUR/RC66/Conf.Doc./12. EUR/RC66/2 Rev.1 Add.1 page 6 6. Private meeting: elections and nominations The Regional Committee is invited to consider, in a private meeting, nominations received for candidatures to WHO bodies and committees (EUR/RC66/7, EUR/RC66/7 Add.1, EUR/RC66/7 Add.2). (a) Nomination of two members of the Executive Board (b) Election of four members of the Standing Committee of the Regional Committee (c) Election of two members of the European Environment and Health Ministerial Board 7. Confirmation of dates and places of regular sessions of the Regional Committee A document on hosting a Regional Committee session outside Copenhagen (EUR/RC66/Inf.Doc./5) is provided for information. The Regional Committee is invited to adopt draft resolution EUR/RC66/Conf.Doc./3. 8. Other matters 9. Closure of the session Technical briefings • Aligning monitoring frameworks – Health 2020 and the Sustainable Development Goals – Monday, 12 September, lunchtime • Access to new high-priced medicines: challenges and opportunities – Tuesday, 13 September, lunchtime • Health laboratory strengthening: an essential component of early warning surveillance and response systems and a national core capacity of the International Health Regulations (2005) – Wednesday, 14 September, lunchtime • Let’s talk country work: the added value of WHO – Wednesday, 14 September, lunchtime Ministerial lunches • Eliminating communicable diseases in the WHO European Region: reaching regional and global targets – Monday, 12 September • Health promotion throughout the life-course – Tuesday, 13 September = = =

Informations clés
Type de document Governing Bodies documents
Date d'adoption
Source Organisation mondiale de la santé